{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:14:24Z","timestamp":1794276864405,"version":"4.9.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100017500","name":"Neuroscience Research Center, Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007269","name":"School of Medicine, Oregon Health and Science University","doi-asserted-by":"publisher","award":["558"],"award-info":[{"award-number":["558"]}],"id":[{"id":"10.13039\/100007269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007269","name":"School of Medicine, Oregon Health and Science University","doi-asserted-by":"publisher","award":["181"],"award-info":[{"award-number":["181"]}],"id":[{"id":"10.13039\/100007269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.neuroscience.2018.08.001","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T22:52:24Z","timestamp":1533941544000},"page":"405-417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["CEPO-Fc (An EPO Derivative) Protects Hippocampus Against A\u03b2-induced Memory Deterioration: A Behavioral and Molecular Study in a Rat Model of A\u03b2 Toxicity"],"prefix":"10.1016","volume":"388","author":[{"given":"Etrat","family":"Hooshmandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Motamedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Moosavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Katinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Zakeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalal","family":"Zaringhalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Maghsoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasoul","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Maghsoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2018.08.001_b0005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3233\/JAD-141389","article-title":"Memory improvement in the A\u03b2PP\/PS1 mouse model of familial Alzheimer\u2019s disease induced by carbamylated-erythropoietin is accompanied by modulation of synaptic genes","volume":"45","author":"Armand-Ug\u00f3n","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0010","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/2836","article-title":"The MAPK cascade is required for mammalian associative learning","volume":"1","author":"Atkins","year":"1998","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0015","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/sj.emboj.7600251","article-title":"PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations","volume":"23","author":"Baki","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0020","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/s00018-005-5597-y","article-title":"Glycogen synthase kinase 3\u03b2 and Alzheimer\u2019s disease: pathophysiological and therapeutic significance","volume":"63","author":"Balaraman","year":"2006","journal-title":"Cell Mol Life Sci CMLS"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0025","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/CCM.0b013e3182204a9c","article-title":"Beneficial effects of carbamylated erythropoeitin on trauma-induced brain edema: proposed molecular mechanisms of action","volume":"39","author":"Bar-Or","year":"2011","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.neuroscience.2018.08.001_b0030","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00008877-200112000-00007","article-title":"LY294002, an inhibitor of phosphoinositide 3-kinase given into rat hippocampus impairs acquisition, consolidation and retrieval of memory for one-trial step-down inhibitory avoidance","volume":"12","author":"Barros","year":"2001","journal-title":"Behav Pahrmacol"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0035","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pneurobio.2006.07.006","article-title":"The paradoxical pro-and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways","volume":"79","author":"Beurel","year":"2006","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0040","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1073\/pnas.0307823100","article-title":"Erythropoietin both protects from and reverses experimental diabetic neuropathy","volume":"101","author":"Bianchi","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0045","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/CCM.0b013e31821cb7b2","article-title":"Reduced brain edema and functional deficits after treatment of diffuse traumatic brain injury by carbamylated erythropoietin derivative","volume":"39","author":"Bouzat","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tibs.2004.03.006","article-title":"Advances in protein kinase B signalling: AKTion on multiple fronts","volume":"29","author":"Brazil","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0055","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.3728-09.2009","article-title":"Adenosine A2A receptor blockade prevents synaptotoxicity and memory disfunction caused by beta-amyloid via p38 mitogen-activated protein kinase pathway","author":"Canas","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0060","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2741\/4295","article-title":"From neurogenesis to neuroprotection in the epilepsy: signalling by erythropoietin","volume":"19","author":"Castaneda-Arellano","year":"2014","journal-title":"Front Biosci (Landmark edition)"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0065","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.redox.2017.09.010","article-title":"Neuroprotective effect of a new variant of Epo nonhematopoietic against oxidative stress","volume":"14","author":"Castillo","year":"2018","journal-title":"Redox Biol"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0070","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nn1482","article-title":"PI3 kinase signaling is required for retrieval and extinction of contextual memory","volume":"8","author":"Chen","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0075","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nn1482","article-title":"PI3 kinase signaling is required for retrieval and extinction of contextual memory","volume":"8","author":"Chen","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0080","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00004647-200205000-00001","article-title":"Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades","volume":"22","author":"Chong","year":"2002","journal-title":"J Cereb Blood Flow Metabol: Off J Int Soc Cereb Blood Flow Metabol"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0085","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.nbd.2008.12.014","article-title":"JNK regulates APP cleavage and degradation in a model of Alzheimer's disease","volume":"33","author":"Colombo","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0090","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1007\/s11064-013-1131-z","article-title":"Neuregulin1beta1 antagonizes apoptosis via ErbB4-dependent activation of PI3-kinase\/Akt in APP\/PS1 transgenic mice","volume":"38","author":"Cui","year":"2013","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0095","doi-asserted-by":"crossref","first-page":"27600","DOI":"10.1038\/srep27600","article-title":"p38 MAPK inhibition improves synaptic plasticity and memory in angiotensin II-dependent hypertensive mice","volume":"6","author":"Dai","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10571-011-9744-8","article-title":"The interaction of amyloid \u03b2 and the receptor for advanced glycation endproducts induces matrix metalloproteinase-2 expression in brain endothelial cells","volume":"32","author":"Du","year":"2012","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0105","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/jnr.21487","article-title":"Integrins mediate \u03b2-amyloid-induced cell-cycle activation and neuronal death","volume":"86","author":"Frasca","year":"2008","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0110","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1038\/jcbfm.2008.59","article-title":"Tissue inhibitor of metalloproteinases protect blood\u2013brain barrier disruption in focal cerebral ischemia","volume":"28","author":"Fujimoto","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainres.2003.12.037","article-title":"Erythropoietin and the nervous system","volume":"1000","author":"Genc","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0304-3940(00)01716-X","article-title":"Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated C57\/BL mice via increasing nitric oxide production","volume":"298","author":"Genc","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12031-015-0622-6","article-title":"The interplay of Akt and ERK in A\u03b2 toxicity and insulin-mediated protection in primary hippocampal cell culture","volume":"57","author":"Ghasemi","year":"2015","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2013.11.034","article-title":"Repeated intra-hippocampal injection of beta-amyloid 25\u201335 induces a reproducible impairment of learning and memory: considering caspase-3 and MAPKs activity","volume":"726","author":"Ghasemi","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuropharm.2014.01.036","article-title":"Insulin protects against A\u03b2-induced spatial memory impairment, hippocampal apoptosis and MAPKs signaling disruption","volume":"85","author":"Ghasemi","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0140","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/iub.187","article-title":"GSK-3: a key player in neurodegeneration and memory","volume":"61","author":"Giese","year":"2009","journal-title":"IUBMB Life"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0145","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.4103\/1673-5374.215240","article-title":"Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor","volume":"12","author":"Hernandez","year":"2017","journal-title":"Neural Regener Res"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1460-9568.2006.05245.x","article-title":"Glycogen synthase kinase-3 inhibition is integral to long-term potentiation","volume":"25","author":"Hooper","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0155","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nlm.2013.08.001","article-title":"Free and nanoencapsulated curcumin suppress beta-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt\/GSK-3beta signaling pathway","volume":"106","author":"Hoppe","year":"2013","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.eplepsyres.2017.04.012","article-title":"P38 MAPK pathway mediates cognitive damage in pentylenetetrazole-induced epilepsy via apoptosis cascade","volume":"133","author":"Huang","year":"2017","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0165","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyy040","article-title":"Modulation of GSK-3beta\/beta-catenin signaling contributes to learning and memory impairment in a rat model of depression","author":"Hui","year":"2018","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0170","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1745-7254.2006.00414.x","article-title":"Effects of sodium ferulate on amyloid-beta-induced MKK3\/MKK6-p38 MAPK-Hsp27 signal pathway and apoptosis in rat hippocampus","volume":"27","author":"Jin","year":"2006","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0175","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018812","article-title":"Neurogenesis in the adult hippocampus","volume":"7","author":"Kempermann","year":"2015","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0180","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1096\/fj.05-3941fje","article-title":"Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1\/-2 and Akt pathways","volume":"19","author":"Kilic","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0185","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1096\/fj.04-2493fje","article-title":"Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1\/-2","volume":"19","author":"Kilic","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003540","article-title":"GSK-3beta is required for memory reconsolidation in adult brain","volume":"3","author":"Kimura","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0195","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000351247","article-title":"Effects of nicorandil in neuroprotective activation of PI3K\/AKT pathways in a cellular model of Alzheimer's disease","volume":"70","author":"Kong","year":"2013","journal-title":"Eur Neurol"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0200","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1242\/jcs.114.16.2903","article-title":"PKB\/Akt: a key mediator of cell proliferation, survival and insulin responses?","volume":"114","author":"Lawlor","year":"2001","journal-title":"J Cell Sci"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0205","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.neuropharm.2010.09.025","article-title":"Comparison of the effects of erythropoietin and its carbamylated derivative on behaviour and hippocampal neurogenesis in mice","volume":"60","author":"Leconte","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0210","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22081287","article-title":"Recent advances in the inhibition of p38 MAPK as a potential strategy for the treatment of Alzheimer\u2019s disease","volume":"22","author":"Lee","year":"2017","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0215","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.1098313","article-title":"Derivatives of erythropoietin that are tissue protective but not erythropoietic","volume":"305","author":"Leist","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0220","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/00004647-200208000-00005","article-title":"Immature and mature cortical neurons engage different apoptotic mechanisms involving caspase-3 and the mitogen-activated protein kinase pathway","volume":"22","author":"Lesuisse","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0225","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neulet.2008.07.007","article-title":"Protective effect of erythropoietin on \u03b2-amyloid-induced PC12 cell death through antioxidant mechanisms","volume":"442","author":"Li","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0230","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.brainres.2011.02.078","article-title":"Regulation of matrix metalloproteinase 2 by oligomeric amyloid \u03b2 protein","volume":"1387","author":"Li","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0235","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1523\/JNEUROSCI.23-05-01605.2003","article-title":"Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway","volume":"23","author":"Li","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0240","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2015.05.031","article-title":"Erythropoietin attenuates Alzheimer-like memory impairments and pathological changes induced by amyloid beta42 in mice","volume":"1618","author":"Li","year":"2015","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0245","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0896-6273(01)00433-0","article-title":"A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala","volume":"31","author":"Lin","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0250","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1046\/j.1471-4159.2001.00472.x","article-title":"Effect of the Alzheimer amyloid fragment A\u03b2 (25\u201335) on Akt\/PKB kinase and survival of PC12 cells","volume":"78","author":"Mart\u00edn","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0255","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1177\/0269881113494939","article-title":"Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Abeta(2)(5)(-)(3)(5) non-transgenic mouse model of Alzheimer's disease","volume":"27","author":"Maurice","year":"2013","journal-title":"J Psychopharmacol (Oxford, England)"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0260","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0896-6273(02)00716-X","article-title":"Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory","volume":"34","author":"Mazzucchelli","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0265","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.mcn.2012.02.005","article-title":"Estrogen activates matrix metalloproteinases-2 and -9 to increase beta amyloid degradation","volume":"49","author":"Merlo","year":"2012","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0270","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1750-3639.2008.00132.x","article-title":"SYMPOSIUM: clearance of A\u03b2 from the brain in Alzheimer\u2019s disease: A\u03b2-degrading enzymes in Alzheimer\u2019s disease","volume":"18","author":"Miners","year":"2008","journal-title":"Brain Pathol"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0275","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.expneurol.2006.09.026","article-title":"Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen\u2013glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures","volume":"204","author":"Montero","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0280","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.neuropharm.2011.12.031","article-title":"Agmatine protects against scopolamine-induced water maze performance impairment and hippocampal ERK and Akt inactivation","volume":"62","author":"Moosavi","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0285","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejphar.2017.12.007","article-title":"Scopolamine-induced passive avoidance memory retrieval deficit is accompanied with hippocampal MMP2, MMP-9 and MAPKs alteration","volume":"819","author":"Moosavi","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0290","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejphar.2014.03.041","article-title":"Agmatine protects against intracerebroventricular streptozotocin-induced water maze memory deficit, hippocampal apoptosis and Akt\/GSK3\u03b2 signaling disruption","volume":"736","author":"Moosavi","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0295","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1167\/iovs.08-2383","article-title":"CTGF is increased in basal deposits and regulates matrix production through the ERK (p42\/p44mapk) MAPK and the p38 MAPK signaling pathways","volume":"50","author":"Nagai","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0300","doi-asserted-by":"crossref","first-page":"S11381","DOI":"10.4137\/JEN.S11381","article-title":"A role for matrix metalloproteinases in nicotine-induced conditioned place preference and relapse in adolescent female rats","volume":"7","author":"Natarajan","year":"2013","journal-title":"J Exp Neurosci JEN"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0305","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1523\/JNEUROSCI.0204-08.2008","article-title":"Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-\u03b2-mediated cortical synaptic dysfunction","volume":"28","author":"Origlia","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0310","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2007.01.029","article-title":"LTP inhibits LTD in the hippocampus via regulation of GSK3\u03b2","volume":"53","author":"Peineau","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0315","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.brainres.2011.09.056","article-title":"Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3\u03b2 decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model","volume":"1426","author":"Ponce-Lopez","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0320","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/JAD-160500","article-title":"An intranasal formulation of erythropoietin (Neuro-EPO) prevents memory deficits and amyloid toxicity in the APP Swe transgenic mouse model of Alzheimer\u2019s disease","volume":"55","author":"Rodriguez Cruz","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0325","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cellsig.2003.07.004","article-title":"Akt\/GSK3\u03b2 serine\/threonine kinases: evidence for a signalling pathway mediated by familial Alzheimer\u2019s disease mutations","volume":"16","author":"Ryder","year":"2004","journal-title":"Cell Signal"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0330","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2169\/internalmedicine.42.142","article-title":"Pleiotropic functions of erythropoietin","volume":"42","author":"Sasaki","year":"2003","journal-title":"Intern Med"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0335","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pep.2006.05.018","article-title":"Biochemical characterization of rhEpo-Fc fusion protein expressed in CHO cells","volume":"49","author":"Schriebl","year":"2006","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0340","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000232557","article-title":"Erythropoietin attenuates hyperoxia-induced cell death by modulation of inflammatory mediators and matrix metalloproteinases","volume":"31","author":"Sifringer","year":"2009","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0345","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000232557","article-title":"Erythropoietin attenuates hyperoxia-induced cell death by modulation of inflammatory mediators and matrix metalloproteinases","volume":"31","author":"Sifringer","year":"2009","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0350","doi-asserted-by":"crossref","first-page":"10962","DOI":"10.1074\/jbc.M312048200","article-title":"Inhibition of ligand-independent ERK1\/2 activity in kidney proximal tubular cells deprived of soluble survival factors up-regulates Akt and prevents apoptosis","volume":"279","author":"Sinha","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0355","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nurt.2008.10.041","article-title":"Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system","volume":"6","author":"Sir\u00e9n","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0360","doi-asserted-by":"crossref","first-page":"12200","DOI":"10.1074\/jbc.275.16.12200","article-title":"Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures","volume":"275","author":"Stanciu","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0365","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1523\/JNEUROSCI.22-17-07380.2002","article-title":"Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways","volume":"22","author":"Stein","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0370","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2362.2010.02292.x","article-title":"Carbamylated erythropoietin increases frataxin independent from the erythropoietin receptor","volume":"40","author":"Sturm","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0375","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1101\/lm.1067808","article-title":"Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex","volume":"15","author":"Sui","year":"2008","journal-title":"Learn Mem (Cold Spring Harbor, NY)"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0380","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.conb.2004.04.001","article-title":"Mitogen-activated protein kinases in synaptic plasticity and memory","volume":"14","author":"Sweatt","year":"2004","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0385","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainres.2013.01.042","article-title":"The neuroprotective and neurorescue effects of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat model of Parkinson\u2019s disease","volume":"1502","author":"Tayra","year":"2013","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0390","doi-asserted-by":"crossref","first-page":"33305","DOI":"10.1074\/jbc.M610390200","article-title":"Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway","volume":"282","author":"Townsend","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0395","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brainresrev.2008.04.007","article-title":"Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia\/ischemia","volume":"59","author":"van der Kooij","year":"2008","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0400","doi-asserted-by":"crossref","first-page":"32462","DOI":"10.1074\/jbc.M706880200","article-title":"The Sonic hedgehog pathway mediates carbamylated erythropoietin-enhanced proliferation and differentiation of adult neural progenitor cells","volume":"282","author":"Wang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0405","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1523\/JNEUROSCI.5380-05.2006","article-title":"Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration","volume":"26","author":"Wang","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0410","article-title":"Matrix metalloproteinases and their multiple roles in Alzheimer\u2019s disease","author":"Wang","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0415","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.surg.2009.03.022","article-title":"Carbamylated erythropoietin protects the myocardium from acute ischemia\/reperfusion injury through a PI3K\/Akt-dependent mechanism","volume":"146","author":"Xu","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0420","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neulet.2013.04.016","article-title":"Ketamine reduces amyloid \u03b2-protein degradation by suppressing neprilysin expression in primary cultured astrocytes","volume":"545","author":"Yamamoto","year":"2013","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0425","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/jnr.20816","article-title":"Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: potential signaling mechanisms","volume":"83","author":"Zhang","year":"2006","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0430","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.cr.7290105","article-title":"MAPK signal pathways in the regulation of cell proliferation in mammalian cells","volume":"12","author":"Zhang","year":"2002","journal-title":"Cell Res"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0435","doi-asserted-by":"crossref","first-page":"12211","DOI":"10.1523\/JNEUROSCI.3321-07.2007","article-title":"Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments","volume":"27","author":"Zhu","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0440","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s11064-005-6872-x","article-title":"P38 activation mediates amyloid-\u03b2 cytotoxicity","volume":"30","author":"Zhu","year":"2005","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuroscience.2018.08.001_b0445","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1124\/jpet.106.107367","article-title":"A death-promoting role for extracellular signal-regulated kinase","volume":"319","author":"Zhuang","year":"2006","journal-title":"J Pharmacol Exp Ther"}],"updated-by":[{"DOI":"10.1016\/j.neuroscience.2025.10.059","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000}}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452218305396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452218305396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T03:03:17Z","timestamp":1768964597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452218305396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":89,"alternative-id":["S0306452218305396"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2018.08.001","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CEPO-Fc (An EPO Derivative) Protects Hippocampus Against A\u03b2-induced Memory Deterioration: A Behavioral and Molecular Study in a Rat Model of A\u03b2 Toxicity","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2018.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 IBRO. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}